Abiopharma

🔍 Paul Elaine (Director)

Company: Sabre Corp (SABR)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 110,497 shares of Common Stock at $1.81 per share (Direct)
  Date: 2026-04-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 197,369.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The restricted stock unit award vests as to 100% of the shares of common stock subject to such award at the end of the one-year period following the grant date, subject to the reporting person's continued service on the board of directors of the Issuer through the vesting date. 100% of the shares received will be deferred pursuant to an election by the reporting person under the Sabre Corporation Non-Employee Director Compensation Deferral Plan.